title: A regulatory role of fibroblast growth factor in the expression of decorin, biglycan, betaglycan and syndecan in osteoblasts from patients with Crouzon's syndrome.
abstract: Bone development is controlled by the autocrine and/or paracrine effects of regulatory molecules. We previously showed that the phenotype of fibroblasts obtained from patients affected by Crouzon's syndrome, an autosomal dominant disease characterized by pathological skull bone development, differed from that of normal cells and was regulated by interleukin treatments. The changes in the relative concentrations of extracellular macromolecules (glycosaminoglycans-GAG, collagen and fibronectin) were associated with abnormal interleukin secretion that affected the microenvironment where the osteogenic processes take place. Mutations in human fibroblast growth factor receptors are now thought to be involved in Crouzon's syndrome. Since coactivation of interleukins and basic fibroblast growth factor (bFGF) is probably implicated in morphogenetic and osteogenic processes and heparan sulphate proteoglycans have a critical role in regulating bFGF activity, the phenotypes of normal and Crouzon osteoblasts were studied and the effects of bFGF on the expression of bFGF, procollagen alpha1 (I), and proteoglycan (PG) genes for biglycan, decorin, betaglycan and syndecan analyzed. Specific human cDNA probes were used to screen the relative levels of mRNA by Northern analysis. Spontaneous or bFGF-modulated release of interleukins was also assayed. The bFGF gene transcript was detected only in Crouzon osteoblasts. We showed for the first time that Crouzon osteoblasts, despite a mutation in the FGF receptor, still responded to exogenous bFGE In fact, the growth factor induced changes in the GAG profile and in the levels of mRNA coding for PG and procollagen alpha1 (I) and down-regulated heparan sulfate GAG chains. ELISA showed that bFGF-induced interleukin secretion differed in normal and Crouzon osteoblasts. The observed differences in PG core protein, procollagen alpha1 (I) and bFGF could be associated with the Crouzon bone phenotype and also should provide further understanding on the molecular basis of the diseased state of bone.
authors.affiliation: Dipartimento di Morfologia ed Embriologia, Università di Ferrara, Italy. pzf@dns.unife.it
authors.forename: M
authors.initials: M
authors.lastname: Bodo
authors.forename: T
authors.initials: T
authors.lastname: Baroni
authors.forename: F
authors.initials: F
authors.lastname: Carinci
authors.forename: E
authors.initials: E
authors.lastname: Becchetti
authors.forename: C
authors.initials: C
authors.lastname: Bellucci
authors.forename: C
authors.initials: C
authors.lastname: Conte
authors.forename: F
authors.initials: F
authors.lastname: Pezzetti
authors.forename: R
authors.initials: R
authors.lastname: Evangelisti
authors.forename: M
authors.initials: M
authors.lastname: Tognon
authors.forename: P
authors.initials: P
authors.lastname: Carinci
mesh_terms: D000262:Adenylyl Cyclases / Q000378:metabolism; D000293:Adolescent; D000328:Adult; D000469:Alkaline Phosphatase / Q000378:metabolism; D058578:Biglycan; D016022:Case-Control Studies; D002454:Cell Differentiation; D002478:Cells, Cultured; D002848:Chromatography, DEAE-Cellulose; D003394:Craniofacial Dysostosis / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D058575:Decorin; D016326:Extracellular Matrix Proteins; D016222:Fibroblast Growth Factor 2 / Q000235:genetics / Q000494:pharmacology / Q000502:physiology*; D019084:Fluorescent Antibody Technique, Indirect; D015870:Gene Expression; D005786:Gene Expression Regulation; D006025:Glycosaminoglycans / Q000096:biosynthesis; D006801:Humans; D007375:Interleukin-1 / Q000378:metabolism; D015850:Interleukin-6 / Q000378:metabolism; D008562:Membrane Glycoproteins / Q000235:genetics*; D010006:Osteoblasts / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D015675:Osteocalcin / Q000378:metabolism; D011347:Procollagen / Q000235:genetics; D011509:Proteoglycans / Q000235:genetics*; D018125:Receptors, Transforming Growth Factor beta / Q000235:genetics*; D013194:Staining and Labeling / Q000379:methods; D053667:Syndecans
chemical_list: C546884:BGN protein, human; D058578:Biglycan; C546878:DCN protein, human; D058575:Decorin; D016326:Extracellular Matrix Proteins; D006025:Glycosaminoglycans; D007375:Interleukin-1; D015850:Interleukin-6; D008562:Membrane Glycoproteins; D011347:Procollagen; D011509:Proteoglycans; D018125:Receptors, Transforming Growth Factor beta; D053667:Syndecans; D016222:Fibroblast Growth Factor 2; D015675:Osteocalcin; C071736:betaglycan; D000469:Alkaline Phosphatase; D000262:Adenylyl Cyclases